| # | Title | Journal | Year | Citations |
|---|
| 1 | Distribution of HLA allele frequencies in 82 Chinese individuals with coronavirus disease‐2019 (COVID‐19) | Hla | 2020 | 152 |
| 2 | Tumor‐associated antigens: Tn antigen, sTn antigen, and T antigen | Hla | 2016 | 139 |
| 3 | Evaluation of the AllType kit for HLA typing using the Ion Torrent S5 XL platform | Hla | 2020 | 134 |
| 4 | HLA allele frequencies and susceptibility to COVID‐19 in a group of 99 Italian patients | Hla | 2020 | 130 |
| 5 | Common, intermediate and well‐documented HLA alleles in world populations: CIWD version 3.0.0 | Hla | 2020 | 93 |
| 6 | The influence of HLA genotype on the severity of COVID‐19 infection | Hla | 2021 | 92 |
| 7 | Determining performance characteristics of an NGS‐based HLA typing method for clinical applications | Hla | 2016 | 89 |
| 8 | Binding affinities of 438 HLA proteins to complete proteomes of seven pandemic viruses and distributions of strongest and weakest HLA peptide binders in populations worldwide | Hla | 2020 | 89 |
| 9 | Improvement in HLA‐typing by new sequence‐specific oligonucleotides kits for HLA‐A, ‐B, and ‐DRB1 loci | Hla | 2018 | 78 |
| 10 | Back to the future: bacteriophages as promising therapeutic tools | Hla | 2016 | 75 |
| 11 | HLAs: Key regulators of T‐cell‐mediated drug hypersensitivity | Hla | 2018 | 72 |
| 12 | HLA common and well‐documented alleles in China | Hla | 2018 | 72 |
| 13 | Dual redundant sequencing strategy: Full‐length gene characterisation of 1056 novel and confirmatory HLA alleles | Hla | 2017 | 70 |
| 14 | Common and well‐documented HLA alleles over all of Europe and within European sub‐regions: A catalogue from the European Federation for Immunogenetics | Hla | 2017 | 68 |
| 15 | Circulating hsa‐miR‐30e‐5p, hsa‐miR‐92a‐3p, and hsa‐miR‐223‐3p may be novel biomarkers in systemic lupus erythematosus | Hla | 2016 | 61 |
| 16 | Single molecule real‐time DNA sequencing of HLA genes at ultra‐high resolution from 126 International HLA and Immunogenetics Workshop cell lines | Hla | 2018 | 59 |
| 17 | HLA‐EMMA: A user‐friendly tool to analyse HLA class I and class II compatibility on the amino acid level | Hla | 2020 | 53 |
| 18 | HLA‐associated antiepileptic drug‐induced cutaneous adverse reactions | Hla | 2019 | 52 |
| 19 | Molecular mechanisms of HLA class I‐mediated immune evasion of human tumors and their role in resistance to immunotherapies | Hla | 2016 | 43 |
| 20 | Autoimmune diseases and 8.1 ancestral haplotype: An update | Hla | 2018 | 43 |
| 21 | Rapid high‐resolution HLA genotyping by MinION Oxford nanopore sequencing for deceased donor organ allocation | Hla | 2020 | 43 |
| 22 | NovAT tool—Reliable novel HLA alleles identification from next‐generation sequencing data | Hla | 2022 | 43 |
| 23 | A multi‐hit hypothesis of bullous pemphigoid and associated neurological disease: Is HLA‐DQB1*03:01, a potential link between immune privileged antigen exposure and epitope spreading? | Hla | 2017 | 38 |
| 24 | Soluble monomers, dimers and HLA‐G‐expressing extracellular vesicles: the three dimensions of structural complexity to use HLA‐G as a clinical biomarker | Hla | 2016 | 36 |
| 25 | Defining the immunogenicity and antigenicity of HLA epitopes is crucial for optimal epitope matching in clinical renal transplantation | Hla | 2017 | 36 |
| 26 | The major histocompatibility complex homozygous inbred Babraham pig as a resource for veterinary and translational medicine | Hla | 2018 | 33 |
| 27 | A comparative reference study for the validation of HLA ‐matching algorithms in the search for allogeneic hematopoietic stem cell donors and cord blood units | Hla | 2016 | 32 |
| 28 | How antigen specificity directs regulatory T‐cell function: self, foreign and engineered specificity | Hla | 2016 | 31 |
| 29 | Impact of HLA in cord blood transplantation outcomes | Hla | 2016 | 31 |
| 30 | Innate lymphoid cells and the MHC | Hla | 2016 | 31 |
| 31 | Improved HLA typing of Class I and Class II alleles from next‐generation sequencing data | Hla | 2019 | 31 |
| 32 | Association of HLA‐DRB1*09:01 with severe COVID‐19 | Hla | 2021 | 31 |
| 33 | Out with the old, in with the new: Virtual versus physical crossmatching in the modern era | Hla | 2019 | 30 |
| 34 | Distribution of HLA‐G extended haplotypes and one HLA‐E polymorphism in a large‐scale study of mother–child dyads with and without severe preeclampsia and eclampsia | Hla | 2016 | 29 |
| 35 | Expression of classical HLA class I molecules: regulation and clinical impacts | Hla | 2016 | 29 |
| 36 | Comparison of sequence‐specific oligonucleotide probe vs next generation sequencing for HLA‐A, B, C, DRB1, DRB3/B4/B5, DQA1, DQB1, DPA1, and DPB1 typing: Toward single‐pass high‐resolution HLA typing in support of solid organ and hematopoietic cell transplant programs | Hla | 2019 | 29 |
| 37 | Association of HLA‐B22 serotype with SARS‐CoV‐2 susceptibility in Hong Kong Chinese patients | Hla | 2021 | 29 |
| 38 | Pre‐transplant soluble CD30 in combination with total DSA but not pre‐transplant C1q‐DSA predicts antibody‐mediated graft loss in presensitized high‐risk kidney transplant recipients | Hla | 2016 | 27 |
| 39 | High‐throughput next‐generation sequencing to genotype six classical HLA loci from 96 donors in a single MiSeq run | Hla | 2017 | 26 |
| 40 | Insights into the polymorphism in HLA‐DRA and its evolutionary relationship with HLA haplotypes | Hla | 2020 | 26 |
| 41 | Barriers to HIV Cure | Hla | 2016 | 25 |
| 42 | Strain‐based HLA association analysis identified HLA‐DRB1 *09:01 associated with modern strain tuberculosis | Hla | 2017 | 25 |
| 43 | Association of HLA‐DRB1 alleles with susceptibility to mixed connective tissue disease in Polish patients | Hla | 2016 | 24 |
| 44 | New insights in HLA‐E polymorphism by refined analysis of the full‐length gene | Hla | 2017 | 23 |
| 45 | The association of the HLA‐A*24:02, B*39:01 and B*39:06 alleles with type 1 diabetes is restricted to specific HLA‐DR/DQ haplotypes in Finns | Hla | 2017 | 23 |
| 46 | HLA genotyping in the clinical laboratory: comparison of next‐generation sequencing methods | Hla | 2016 | 22 |
| 47 | The complexity and diversity of major histocompatibility complex challenge disease association studies | Hla | 2019 | 22 |
| 48 | Hematopoietic stem cell transplantation and cellular therapy | Hla | 2017 | 21 |
| 49 | Common and well‐documented HLA alleles of German stem cell donors by haplotype frequency estimation | Hla | 2018 | 21 |
| 50 | Toward defining the immunogenicity of HLA epitopes: Impact of HLA class I eplets on antibody formation during pregnancy | Hla | 2020 | 21 |
